Medicus Pharma Ltd. (MDCXW)
NASDAQ: MDCXW
· Real-Time Price · USD
0.83
0.01 (1.57%)
At close: Jun 13, 2025, 2:56 PM
0.83
0.00%
After-hours: Jun 13, 2025, 04:00 PM EDT
Company Description
Medicus Pharma Ltd. is a clinical-stage biotech company focused on accelerating the development of novel therapeutic assets.
Their lead subsidiary, SkinJect Inc., is developing a non-invasive treatment for basal cell carcinoma using a dissolvable microneedle patch to deliver chemotherapeutic agents directly to tumor cells.
Medicus Pharma Ltd.
| Country | CA |
| IPO Date | Nov 14, 2024 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 12 |
| CEO | Dr. Raza Bokhari M.B.A., M.D., MBA |
Contact Details
Address: One First Canadian Place, Suite 3400 Toronto, ON M5X 1A Toronto, CA | |
| Website | https://medicuspharma.com/ |
Stock Details
| Ticker Symbol | MDCXW |
| Exchange | NASDAQ |
| Fiscal Year | n/a |
| Reporting Currency | USD |
| CIK Code | 0001997296 |
| CUSIP Number | n/a |
| ISIN Number | CA58471K1113 |
| Employer ID | 98-1778211 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Dr. Raza Bokhari M.B.A., M.D., MBA | Chief Executive Officer & Executive Chairman |
| James P. Quinlan CPA | Chief Financial Officer |
| Anna Baran-Djokovic J.D. | Senior Vice President of Investor Relations |
| Carolyn Bonner | President |
| Dr. Edward J. Brennan Jr., F.A.C.S., FACS, M.D. | Chief Scientific Officer and Head of R&D Program |
| Dr. Faisal Mehmud M.D. | Chief Medical Officer |
| Maryann Adesso | Chief of Staff |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jun 06, 2025 | 424B3 | Filing |
| Jun 06, 2025 | 424B3 | Filing |
| Jun 06, 2025 | 253G2 | Filing |
| Jun 06, 2025 | 424B3 | Filing |
| Jun 05, 2025 | 8-K | Current Report |
| Jun 03, 2025 | 424B3 | Filing |
| Jun 03, 2025 | 424B3 | Filing |
| Jun 03, 2025 | 424B3 | Filing |
| Jun 03, 2025 | 253G2 | Filing |
| Jun 02, 2025 | 8-K | Current Report |